Related Experiment Videos
1 -Antitrypsin deficiency: a variant with no detectable 1 -antitrypsin
Science (New York, N.Y.)
|July 6, 1973
Summary
A genetic variant of alpha(1)-antitrypsin deficiency was identified in a patient with severe pulmonary emphysema. This deficiency prevents the body from producing functional alpha(1)-antitrypsin, leading to lung damage.
Area of Science:
- Pulmonary Medicine
- Genetics
- Biochemistry
Background:
- Alpha(1)-antitrypsin deficiency is a genetic disorder that can lead to early-onset emphysema.
- Early detection and diagnosis are crucial for managing the condition and preventing further lung damage.
Purpose of the Study:
- To investigate the cause of severe pulmonary emphysema in a young adult.
- To identify potential genetic factors contributing to alpha(1)-antitrypsin deficiency.
Main Methods:
- Serum analysis using agarose electrophoresis, immunoelectrophoresis, and double diffusion in agarose gel.
- Alpha(1)-antitrypsin genetic typing via starch-gel electrophoresis and crossed antigen-antibody electrophoresis.
- Family member screening to assess genetic transmission.
Main Results:
- No detectable alpha(1)-antitrypsin in the patient's serum.
- Absence of a circulating alpha(1)-antitrypsin inactivator.
- Evidence of genetic transmission of a novel alpha(1)-antitrypsin variant within the family.
Conclusions:
- The patient's pulmonary emphysema is linked to a newly identified genetic variant of alpha(1)-antitrypsin deficiency.
- This variant results in a complete lack of detectable alpha(1)-antitrypsin.
- Genetic screening of family members confirmed the heritability of this condition.